HIV/AIDS Drug Resistance
K103N is the most common mutation in patients receiving antiretroviral therapy in Kampala
Published in TB and Outbreaks Week, February 21st, 2006
According to a recent study from the United States, "Access to antiretroviral therapy and human immunodeficiency virus (HIV) care is increasing in resource-limited settings. We evaluated clinical, behavioral, and demographic risk factors associated with virologic suppression in a public, urban clinic in Kampala, Uganda.
"We conducted a cross-sectional, observational study of 137 HIV-infected patients who were receiving antiretroviral therapy at the infectious diseases clinic at Mulago Hospital (Kampala). We measured the prevalence of viral suppression,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Drug Resistance
Treatment of multidrug resistant TB led to fluoroquinolone resistance in Taiwan - Food Safety
Multiple-restaurant Shigella flexneri serotype 2a infection outbreak traced to tomatoes - Nosocomial Infections
Serratia marcescens bacteriuria outbreaks occurred in neurosurgical ICU - Nosocomial Infections
Infection control measures failed to control carbapenem-resistant P. aeruginosa spread - Nosocomial Infections
Simultaneous S. marcescens and K. pneumoniae outbreak occurred in a neonatal ICU - Allergy & Immunology
TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal MTB resistance - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
